• Menu
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Before Header

This project has received funding from the European Union’s Horizon 2020
research and innovation programme under grant agreement No [820523]

Phagovet

Phagovet

Header Right

 

  • Home
  • The Phagovet Project
  • Work packages – Phagovet | Poultry
  • Partners
  • News and events
  • Contact
  • Home
  • The Phagovet Project
  • Work packages – Phagovet | Poultry
  • Partners
  • News and events
  • Contact
gut microbiota of chickens in a commercial farm treated with a Salmonella phage cocktail

The gut microbiota of chickens in a commercial farm treated with a Salmonella phage cocktail

January 19, 2022

Salmonella phage cocktail

The health, metabolism and immunity of broiler chickens can be strongly influenced by the microbiota in their gut. Certain bacteria can have a positive effect, while others have a negative impact on animal productivity. Therefore, new strategies to control pathogens without upsetting the delicate balance of the microbial community are critical.

Phages, viral parasites that specifically target bacterial cells, offer such a solution.

The objective of this study was to characterize the microbial community in broiler chickens treated with a phage cocktail targeting Salmonella.

In field trials, this approach was found to successfully control Salmonella without upsetting the balance of the overall microbiota. These results demonstrate the potential of phages as a promising alternative to conventional antibiotics in broiler production.


The authors Viviana Clavijo, Tatiana Morales, Martha Josefina Vives-Flores, and Alejandro Reyes Muñoz published their findings in the article The gut microbiota of chickens in a commercial farm treated with a Salmonella phage cocktail, dated 19 January 2022.

Key findings:

  • The microbiota in the intestine of broiler chickens influences the health, metabolism and immunity of the animals both positively and negatively.
  • Phages are a promising antimicrobial alternative that selectively targets pathogens without disrupting the microbiota.
  • The objective of this study is to further characterize the commensal microbial community at production scale in broiler chickens treated with Salmonella phage treatment.
  • We studied the microbiota in the caecum of broiler chickens raised in a commercial housing system in which the birds were administered a phage cocktail against Salmonella.
  • Our results showed that the addition of the phage cocktail resulted in a significant reduction in Campylobacter and an increase in Butyricimonas, Helicobacter and Rikenellaceae.
gut microbiota of chickens in a commercial farm treated with a Salmonella phage cocktail

Abstract

The microbiota in broiler chicken intestines affects the animals’ health, metabolism, and immunity both positively and negatively. Accordingly, it has a significant impact on animal productivity.

Phages, host-specific parasites of bacterial cells, are a promising antimicrobial alternative that selectively target pathogens without disturbing the microbiota.

The purpose of this study is to further characterize the commensal microbial community at production scale in broiler chickens treated with a Salmonella phage treatment.

We evaluated the cecal microbiota of broilers reared in a commercial farming system where a phage cocktail against Salmonella, SalmoFree was supplied to animals.

To do so, two field trials were conducted, incorporating three doses of phages in the broilers’ drinking water. Our results showed that the core microbiome (taxa that were present in more than 50% of samples) contained species that are key to microbiota adaptation in the last stage of the production cycle. Among these, there are some important degraders of complex polysaccharides and producers of short chain fatty acids (SCFA) such as Eisenbergiella and Lachnoclostridium.

The phage cocktail did not affect the normal development of the microbiota’s structure.

The addition of the phage cocktail resulted in a significant reduction in Campylobacter and an increase in Butyricimonas, Helicobacter and Rikenellaceae, which are common inhabitants in chicken gut with known negative and positive effects on their health and metabolism.

Altogether, we consider that these results contribute valuable information to the implementation of large-scale phage therapy technologies.

© 2022. The Authors.


Previous Post: «Chicken liver is a potential reservoir of bacteriophages and phage-derived particles containing antibiotic resistance genes A therapeutic approach in animal health with bacteriophages – Phagovet
Next Post: Salmonella phage CKT1 significantly relieves the body weight loss of chicks by normalizing the abnormal intestinal microbiome caused by hypervirulent Salmonella Pullorum Salmonella phages and salmonella pullorum»

Primary Sidebar

Categories

  • Events
  • News
  • Scientific article
  • Uncategorised

Follow us on LinkedIN

Latest news

Role of Bacteriophages for Optimized Health and Production of Poultry

Bacteriophages and the production of poultry The poultry sector has …

Anti-Salmonella polyvinyl alcohol coating containing a virulent phage PBSE191 and its application on chicken eggshell

Anti-Salmonella polyvinyl alcohol coating - phage PBSE191 Antibiotic …

Characterization and Genomic Analysis of Escherichia coli O157:H7 Phage UAE_MI-01 Isolated from Birds

Genomic Analysis of Escherichia coli O157:H7 - Phages Escherichia coli …

Endolysins of bacteriophage vB_Sal-S-S10 can naturally lyse Salmonella enteritidis

Bacteriophage - Salmonella enteritidis The holin-endolysin lysis system …

Examining the effects of Salmonella phage on the caecal microbiota and metabolome features in Salmonella-free broilers

Salmonella phages Bacteriophages, or phages, are viruses that can infect …

Footer

Partners

  • ALS Life Sciences
  • CECAV
  • UAB
  • VETWORKS

Navigate

  • Home
  • The Phagovet Project
  • Work packages – Phagovet | Poultry
  • Partners
  • News and events
  • Contact

Copyright © 2026 · Phagovet EU | Privacy statement